Maram M Aboromia

Association between fibroblast growth factor 23 and left ventricular hypertrophy in Egyptian patients on regular hemodialysis

Abstract Background Cardiovascular disease remains the leading cause of mortality in end-stage renal disease (ESRD) patients, with left ventricular hypertrophy (LVH) representing a prevalent and prognostically significant complication. Fibroblast growth factor 23 (FGF23), a bone-...